IBDEI0CG ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16622,2)
 ;;=^295283
 ;;^UTILITY(U,$J,358.3,16623,0)
 ;;=V15.82^^107^962^79
 ;;^UTILITY(U,$J,358.3,16623,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16623,1,4,0)
 ;;=4^V15.82
 ;;^UTILITY(U,$J,358.3,16623,1,5,0)
 ;;=5^Personal h/o Tobacco Use
 ;;^UTILITY(U,$J,358.3,16623,2)
 ;;=Hx of Tobacco Use (not current)^303405
 ;;^UTILITY(U,$J,358.3,16624,0)
 ;;=V12.01^^107^962^77
 ;;^UTILITY(U,$J,358.3,16624,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16624,1,4,0)
 ;;=4^V12.01
 ;;^UTILITY(U,$J,358.3,16624,1,5,0)
 ;;=5^Personal h/o TB
 ;;^UTILITY(U,$J,358.3,16624,2)
 ;;=Hx of TB^303393
 ;;^UTILITY(U,$J,358.3,16625,0)
 ;;=V12.51^^107^962^81
 ;;^UTILITY(U,$J,358.3,16625,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16625,1,4,0)
 ;;=4^V12.51
 ;;^UTILITY(U,$J,358.3,16625,1,5,0)
 ;;=5^Personal h/o Venous Thrombosis/Embolism
 ;;^UTILITY(U,$J,358.3,16625,2)
 ;;=^303397
 ;;^UTILITY(U,$J,358.3,16626,0)
 ;;=V17.89^^107^962^25
 ;;^UTILITY(U,$J,358.3,16626,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16626,1,4,0)
 ;;=4^V17.89
 ;;^UTILITY(U,$J,358.3,16626,1,5,0)
 ;;=5^Family h/o Musculosk Dis
 ;;^UTILITY(U,$J,358.3,16626,2)
 ;;=^332861
 ;;^UTILITY(U,$J,358.3,16627,0)
 ;;=V12.54^^107^962^76
 ;;^UTILITY(U,$J,358.3,16627,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16627,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,16627,1,5,0)
 ;;=5^Personal h/o Stroke w/o Residual
 ;;^UTILITY(U,$J,358.3,16627,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,16628,0)
 ;;=V15.88^^107^962^50
 ;;^UTILITY(U,$J,358.3,16628,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16628,1,4,0)
 ;;=4^V15.88
 ;;^UTILITY(U,$J,358.3,16628,1,5,0)
 ;;=5^Personal h/o Fall(s)
 ;;^UTILITY(U,$J,358.3,16628,2)
 ;;=^332859
 ;;^UTILITY(U,$J,358.3,16629,0)
 ;;=V15.52^^107^962^80
 ;;^UTILITY(U,$J,358.3,16629,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16629,1,4,0)
 ;;=4^V15.52
 ;;^UTILITY(U,$J,358.3,16629,1,5,0)
 ;;=5^Personal h/o Traum Brain Inj
 ;;^UTILITY(U,$J,358.3,16629,2)
 ;;=^338495
 ;;^UTILITY(U,$J,358.3,16630,0)
 ;;=V12.55^^107^962^70
 ;;^UTILITY(U,$J,358.3,16630,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16630,1,4,0)
 ;;=4^V12.55
 ;;^UTILITY(U,$J,358.3,16630,1,5,0)
 ;;=5^Personal h/o Pulmonary Embolism
 ;;^UTILITY(U,$J,358.3,16630,2)
 ;;=^340615
 ;;^UTILITY(U,$J,358.3,16631,0)
 ;;=V58.61^^107^962^1
 ;;^UTILITY(U,$J,358.3,16631,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16631,1,4,0)
 ;;=4^V58.61
 ;;^UTILITY(U,$J,358.3,16631,1,5,0)
 ;;=5^Anticoag Rx,Chronic
 ;;^UTILITY(U,$J,358.3,16631,2)
 ;;=^303459
 ;;^UTILITY(U,$J,358.3,16632,0)
 ;;=V12.72^^107^962^2
 ;;^UTILITY(U,$J,358.3,16632,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16632,1,4,0)
 ;;=4^V12.72
 ;;^UTILITY(U,$J,358.3,16632,1,5,0)
 ;;=5^Colon Polyps (Removed)
 ;;^UTILITY(U,$J,358.3,16632,2)
 ;;=^303401
 ;;^UTILITY(U,$J,358.3,16633,0)
 ;;=V25.09^^107^962^3
 ;;^UTILITY(U,$J,358.3,16633,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16633,1,4,0)
 ;;=4^V25.09
 ;;^UTILITY(U,$J,358.3,16633,1,5,0)
 ;;=5^Contraceptive Counseling
 ;;^UTILITY(U,$J,358.3,16633,2)
 ;;=^87608
 ;;^UTILITY(U,$J,358.3,16634,0)
 ;;=V25.9^^107^962^4
 ;;^UTILITY(U,$J,358.3,16634,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16634,1,4,0)
 ;;=4^V25.9
 ;;^UTILITY(U,$J,358.3,16634,1,5,0)
 ;;=5^Contraceptive Management
 ;;^UTILITY(U,$J,358.3,16634,2)
 ;;=^276356
 ;;^UTILITY(U,$J,358.3,16635,0)
 ;;=V65.40^^107^962^5
 ;;^UTILITY(U,$J,358.3,16635,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16635,1,4,0)
 ;;=4^V65.40
 ;;^UTILITY(U,$J,358.3,16635,1,5,0)
 ;;=5^Counseling NOS
 ;;^UTILITY(U,$J,358.3,16635,2)
 ;;=^87449
 ;;^UTILITY(U,$J,358.3,16636,0)
 ;;=V58.83^^107^962^6
 ;;^UTILITY(U,$J,358.3,16636,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16636,1,4,0)
 ;;=4^V58.83
 ;;^UTILITY(U,$J,358.3,16636,1,5,0)
 ;;=5^Encounter for Therapeutic Drug Monitor
 ;;^UTILITY(U,$J,358.3,16636,2)
 ;;=^322076
 ;;^UTILITY(U,$J,358.3,16637,0)
 ;;=V18.51^^107^962^18
 ;;^UTILITY(U,$J,358.3,16637,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16637,1,4,0)
 ;;=4^V18.51
 ;;^UTILITY(U,$J,358.3,16637,1,5,0)
 ;;=5^Family h/o Colonic Polyps
 ;;^UTILITY(U,$J,358.3,16637,2)
 ;;=^334209
 ;;^UTILITY(U,$J,358.3,16638,0)
 ;;=V18.59^^107^962^22
 ;;^UTILITY(U,$J,358.3,16638,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16638,1,4,0)
 ;;=4^V18.59
 ;;^UTILITY(U,$J,358.3,16638,1,5,0)
 ;;=5^Family h/o GI Problems
 ;;^UTILITY(U,$J,358.3,16638,2)
 ;;=^334210
 ;;^UTILITY(U,$J,358.3,16639,0)
 ;;=V68.09^^107^962^31
 ;;^UTILITY(U,$J,358.3,16639,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16639,1,4,0)
 ;;=4^V68.09
 ;;^UTILITY(U,$J,358.3,16639,1,5,0)
 ;;=5^Form Completion
 ;;^UTILITY(U,$J,358.3,16639,2)
 ;;=^335321
 ;;^UTILITY(U,$J,358.3,16640,0)
 ;;=V10.51^^107^962^39
 ;;^UTILITY(U,$J,358.3,16640,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16640,1,4,0)
 ;;=4^V10.51
 ;;^UTILITY(U,$J,358.3,16640,1,5,0)
 ;;=5^Personal h/o Bladder Cancer
 ;;^UTILITY(U,$J,358.3,16640,2)
 ;;=^295228
 ;;^UTILITY(U,$J,358.3,16641,0)
 ;;=V10.3^^107^962^40
 ;;^UTILITY(U,$J,358.3,16641,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16641,1,4,0)
 ;;=4^V10.3
 ;;^UTILITY(U,$J,358.3,16641,1,5,0)
 ;;=5^Personal h/o Breast Cancer
 ;;^UTILITY(U,$J,358.3,16641,2)
 ;;=^295217
 ;;^UTILITY(U,$J,358.3,16642,0)
 ;;=V10.41^^107^962^41
 ;;^UTILITY(U,$J,358.3,16642,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16642,1,4,0)
 ;;=4^V10.41
 ;;^UTILITY(U,$J,358.3,16642,1,5,0)
 ;;=5^Personal h/o Cervical Cancer
 ;;^UTILITY(U,$J,358.3,16642,2)
 ;;=^295219
 ;;^UTILITY(U,$J,358.3,16643,0)
 ;;=V10.05^^107^962^42
 ;;^UTILITY(U,$J,358.3,16643,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16643,1,4,0)
 ;;=4^V10.05
 ;;^UTILITY(U,$J,358.3,16643,1,5,0)
 ;;=5^Personal h/o Colon Cancer
 ;;^UTILITY(U,$J,358.3,16643,2)
 ;;=^295207
 ;;^UTILITY(U,$J,358.3,16644,0)
 ;;=V10.03^^107^962^47
 ;;^UTILITY(U,$J,358.3,16644,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16644,1,4,0)
 ;;=4^V10.03
 ;;^UTILITY(U,$J,358.3,16644,1,5,0)
 ;;=5^Personal h/o Esophageal Cancer
 ;;^UTILITY(U,$J,358.3,16644,2)
 ;;=^295205
 ;;^UTILITY(U,$J,358.3,16645,0)
 ;;=V10.21^^107^962^55
 ;;^UTILITY(U,$J,358.3,16645,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16645,1,4,0)
 ;;=4^V10.21
 ;;^UTILITY(U,$J,358.3,16645,1,5,0)
 ;;=5^Personal h/o Laryngeal Cancer
 ;;^UTILITY(U,$J,358.3,16645,2)
 ;;=^295214
 ;;^UTILITY(U,$J,358.3,16646,0)
 ;;=V10.60^^107^962^56
 ;;^UTILITY(U,$J,358.3,16646,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16646,1,4,0)
 ;;=4^V10.60
 ;;^UTILITY(U,$J,358.3,16646,1,5,0)
 ;;=5^Personal h/o Leukemia
 ;;^UTILITY(U,$J,358.3,16646,2)
 ;;=^295231
 ;;^UTILITY(U,$J,358.3,16647,0)
 ;;=V10.11^^107^962^57
 ;;^UTILITY(U,$J,358.3,16647,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16647,1,4,0)
 ;;=4^V10.11
 ;;^UTILITY(U,$J,358.3,16647,1,5,0)
 ;;=5^Personal h/o Lung Cancer
 ;;^UTILITY(U,$J,358.3,16647,2)
 ;;=^295211
 ;;^UTILITY(U,$J,358.3,16648,0)
 ;;=V10.79^^107^962^59
 ;;^UTILITY(U,$J,358.3,16648,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16648,1,4,0)
 ;;=4^V10.79
 ;;^UTILITY(U,$J,358.3,16648,1,5,0)
 ;;=5^Personal h/o Lymphoma
 ;;^UTILITY(U,$J,358.3,16648,2)
 ;;=^295238
 ;;^UTILITY(U,$J,358.3,16649,0)
 ;;=V10.02^^107^962^65
 ;;^UTILITY(U,$J,358.3,16649,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16649,1,4,0)
 ;;=4^V10.02
 ;;^UTILITY(U,$J,358.3,16649,1,5,0)
 ;;=5^Personal h/o Oral Cavity/Pharynx Cancer
 ;;^UTILITY(U,$J,358.3,16649,2)
 ;;=^295204
 ;;^UTILITY(U,$J,358.3,16650,0)
 ;;=V10.06^^107^962^71
 ;;^UTILITY(U,$J,358.3,16650,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16650,1,4,0)
 ;;=4^V10.06
 ;;^UTILITY(U,$J,358.3,16650,1,5,0)
 ;;=5^Personal h/o Rectal/Anal Cancer
 ;;^UTILITY(U,$J,358.3,16650,2)
 ;;=^295208
 ;;^UTILITY(U,$J,358.3,16651,0)
 ;;=V10.52^^107^962^72
 ;;^UTILITY(U,$J,358.3,16651,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16651,1,4,0)
 ;;=4^V10.52
 ;;^UTILITY(U,$J,358.3,16651,1,5,0)
 ;;=5^Personal h/o Renal Cancer
 ;;^UTILITY(U,$J,358.3,16651,2)
 ;;=^295229
 ;;^UTILITY(U,$J,358.3,16652,0)
 ;;=V10.04^^107^962^75
 ;;^UTILITY(U,$J,358.3,16652,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16652,1,4,0)
 ;;=4^V10.04
 ;;^UTILITY(U,$J,358.3,16652,1,5,0)
 ;;=5^Personal h/o Stomach Cancer
 ;;^UTILITY(U,$J,358.3,16652,2)
 ;;=^295206
 ;;^UTILITY(U,$J,358.3,16653,0)
 ;;=V10.47^^107^962^78
 ;;^UTILITY(U,$J,358.3,16653,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16653,1,4,0)
 ;;=4^V10.47
 ;;^UTILITY(U,$J,358.3,16653,1,5,0)
 ;;=5^Personal h/o Testicular Cancer
 ;;^UTILITY(U,$J,358.3,16653,2)
 ;;=^295225
 ;;^UTILITY(U,$J,358.3,16654,0)
 ;;=V08.^^107^962^32
 ;;^UTILITY(U,$J,358.3,16654,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16654,1,4,0)
 ;;=4^V08.
 ;;^UTILITY(U,$J,358.3,16654,1,5,0)
 ;;=5^HIV + Status (Asymptomatic)
 ;;^UTILITY(U,$J,358.3,16654,2)
 ;;=^303392
 ;;^UTILITY(U,$J,358.3,16655,0)
 ;;=V07.4^^107^962^33
 ;;^UTILITY(U,$J,358.3,16655,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16655,1,4,0)
 ;;=4^V07.4
 ;;^UTILITY(U,$J,358.3,16655,1,5,0)
 ;;=5^Hormone Replacement Therapy
 ;;^UTILITY(U,$J,358.3,16655,2)
 ;;=^331975
 ;;^UTILITY(U,$J,358.3,16656,0)
 ;;=V13.59^^107^962^63
 ;;^UTILITY(U,$J,358.3,16656,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16656,1,4,0)
 ;;=4^V13.59
 ;;^UTILITY(U,$J,358.3,16656,1,5,0)
 ;;=5^Personal h/o Musculoskletl Dis
 ;;^UTILITY(U,$J,358.3,16656,2)
 ;;=^295268
 ;;^UTILITY(U,$J,358.3,16657,0)
 ;;=V12.51^^107^962^45
 ;;^UTILITY(U,$J,358.3,16657,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16657,1,4,0)
 ;;=4^V12.51
 ;;^UTILITY(U,$J,358.3,16657,1,5,0)
 ;;=5^Personal h/o DVT
 ;;^UTILITY(U,$J,358.3,16657,2)
 ;;=^303397
 ;;^UTILITY(U,$J,358.3,16658,0)
 ;;=V11.2^^107^962^46
 ;;^UTILITY(U,$J,358.3,16658,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16658,1,4,0)
 ;;=4^V11.2
 ;;^UTILITY(U,$J,358.3,16658,1,5,0)
 ;;=5^Personal h/o Dysthymia
 ;;^UTILITY(U,$J,358.3,16658,2)
 ;;=^295251
 ;;^UTILITY(U,$J,358.3,16659,0)
 ;;=V13.01^^107^962^54
 ;;^UTILITY(U,$J,358.3,16659,1,0)
 ;;=^358.31IA^5^2
